Institutional & Family Asset Management, LLC Guardant Health, Inc. Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$17.13 - $26.91 $7,862 - $12,351	-459 Reduced 97.87%	10 $0
Q4 2023 Feb 06, 2024	SELL	$21.58 - $29.5 $323 - $442	-15 Reduced 3.1%	469 $12,000
Q3 2023 Nov 13, 2023	BUY	$25.8 - $39.97 $258 - $399	10 Added 2.11%	484 $14,000
Q2 2023 Aug 09, 2023	SELL	$20.94 - $38.01 $167 - $304	-8 Reduced 1.66%	474 $16,000
Q1 2023 May 08, 2023	SELL	$22.92 - $33.76 $848 - $1,249	-37 Reduced 7.13%	482 $11,000
Q4 2022 Feb 08, 2023	SELL	$25.44 - $59.78 $101 - $239	-4 Reduced 0.76%	519 $14,000
Q1 2022 May 11, 2022	SELL	$48.25 - $100.49 $5,452 - $11,355	-113 Reduced 17.77%	523 $35,000
Q2 2021 Aug 10, 2021	BUY	$109.77 - $165.68 $12,184 - $18,390	111 Added 21.14%	636 $79,000
Q1 2021 May 06, 2021	SELL	$127.04 - $179.1 $508 - $716	-4 Reduced 0.76%	525 $80,000
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $241 - $390	4 Added 0.76%	529 $43,000
Q1 2020 May 14, 2020	BUY	$59.04 - $88.81 $30,996 - $46,625	525 New	525 $37,000

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

Vanguard Group Inc Valley Forge, PA

11.7M
Shares

$430 Million
0.0% of portfolio
Black Rock Inc. New York, NY

11.2M
Shares

$413 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.1M
Shares

$372 Million
0.04% of portfolio
Cadian Capital Management, LP New York, NY

6.93M
Shares

$254 Million
8.13% of portfolio
Deep Track Capital, LP Greenwich, CT

6M
Shares

$220 Million
5.07% of portfolio

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.75B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account